These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 28439468)
21. Altered material properties are responsible for bone fragility in rats with chronic kidney injury. Iwasaki Y; Kazama JJ; Yamato H; Matsugaki A; Nakano T; Fukagawa M Bone; 2015 Dec; 81():247-254. PubMed ID: 26187196 [TBL] [Abstract][Full Text] [Related]
22. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism. Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373 [TBL] [Abstract][Full Text] [Related]
23. [Tryptophan and its metabolites in renal allograft recipients]. Myśliwiec P; Myśliwiec H; Pawlak D; Dadan J; Buczko W; Pawlak K Przegl Lek; 2009; 66(3):115-8. PubMed ID: 19689033 [TBL] [Abstract][Full Text] [Related]
24. A sensitive UPLC-MS/MS method for the simultaneous determination of the metabolites in the tryptophan pathway in rat plasma. Dai M; Wang Q; Kou S; Li X; Jiang Z; Sun L; Huang X J Pharm Biomed Anal; 2022 Sep; 219():114979. PubMed ID: 35932697 [TBL] [Abstract][Full Text] [Related]
25. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336 [TBL] [Abstract][Full Text] [Related]
26. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
27. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy. Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of peripheral serotonin synthesis by LP533401 and disturbances in calciotropic hormones attenuated excessive osteoblastogenesis with simultaneous improvement of bone mineral status in 5/6 nephrectomized rats. Pawlak D; Domaniewski T; Sieklucka B; Jakuc M; Pawlak K Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165528. PubMed ID: 31398464 [TBL] [Abstract][Full Text] [Related]
29. Tryptophan circuit in fatigue: From blood to brain and cognition. Yamashita M; Yamamoto T Brain Res; 2017 Nov; 1675():116-126. PubMed ID: 28893581 [TBL] [Abstract][Full Text] [Related]
30. The effect of age on the enzyme activities of tryptophan metabolism along the kynurenine pathway in rats. Comai S; Costa CV; Ragazzi E; Bertazzo A; Allegri G Clin Chim Acta; 2005 Oct; 360(1-2):67-80. PubMed ID: 15970278 [TBL] [Abstract][Full Text] [Related]
31. Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study. Colle R; Masson P; Verstuyft C; Fève B; Werner E; Boursier-Neyret C; Walther B; David DJ; Boniface B; Falissard B; Chanson P; Corruble E; Becquemont L Psychiatry Clin Neurosci; 2020 Feb; 74(2):112-117. PubMed ID: 31599111 [TBL] [Abstract][Full Text] [Related]
32. Serum PTH, PTH1R/ATF4 pathway, and the sRANKL/OPG system in bone as a new link between bone growth, cross-sectional geometry, and strength in young rats with experimental chronic kidney disease. Sieklucka B; Pawlak D; Domaniewski T; Hermanowicz J; Lipowicz P; Doroszko M; Pawlak K Cytokine; 2021 Dec; 148():155685. PubMed ID: 34411988 [TBL] [Abstract][Full Text] [Related]
33. Plasma Kynurenine: A Promising Marker for the Assessment of Renal Functions. Brekdar F; Khayat MI; Zrieki A Int J Tryptophan Res; 2022; 15():11786469221102093. PubMed ID: 35651666 [TBL] [Abstract][Full Text] [Related]
34. The impact of peripheral serotonin on leptin-brain serotonin axis, bone metabolism and strength in growing rats with experimental chronic kidney disease. Pawlak D; Domaniewski T; Znorko B; Oksztulska-Kolanek E; Lipowicz P; Doroszko M; Karbowska M; Pawlak K Bone; 2017 Dec; 105():1-10. PubMed ID: 28797891 [TBL] [Abstract][Full Text] [Related]
35. Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease. Benitez T; VanDerWoude E; Han Y; Byun J; Konje VC; Gillespie BW; Saran R; Mathew AV Clin Kidney J; 2022 Oct; 15(10):1952-1965. PubMed ID: 36158159 [TBL] [Abstract][Full Text] [Related]
36. Relationship of tryptophan metabolites with the type and severity of multiple sclerosis. Isık SMT; Onmaz DE; Ekmekci AH; Ozturk S; Unlu A; Abusoglu S Mult Scler Relat Disord; 2023 Sep; 77():104898. PubMed ID: 37481818 [TBL] [Abstract][Full Text] [Related]
37. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome. Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725 [TBL] [Abstract][Full Text] [Related]
38. Brain Skorobogatov K; De Picker L; Verkerk R; Coppens V; Leboyer M; Müller N; Morrens M Front Immunol; 2021; 12():716980. PubMed ID: 34630391 [TBL] [Abstract][Full Text] [Related]
39. New insights into tryptophan and its metabolites in the regulation of bone metabolism. Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]